Full-Time

Head of Revenue Cycle Management / Revenue Cycle Operations

Revenue Cycle Management

Posted on 9/9/2025

Osmind

Osmind

51-200 employees

Mental health EMR platform with billing

Compensation Overview

$170k - $220k/yr

Remote in USA

Remote

Category
Finance & Banking (1)
Requirements
  • 10+ years of healthcare revenue cycle management (RCM) and credentialing experience, including 5+ years in leadership roles
  • Extensive knowledge of behavioral health billing
  • Direct experience working and interfacing with clinicians and practice staff members
  • Excellent communication, organization, and client-facing skills; ability to translate complex RCM topics to stakeholders unfamiliar with billing
Responsibilities
  • Develop and execute the overall RCM strategy and account management for scaling our RCM services offering beyond the pilot phase
  • Set and monitor KPIs to ensure operational excellence and financial targets
  • Manage vendor relationships and partnerships
  • Oversee team performance and professional development
  • Directly oversee our billing partner and internal team to drive maximum billing and credentialing performance
  • Set and achieve revenue cycle performance targets, such as clean claim rates, days in AR, and denial rates
  • Develop reporting frameworks to track team and financial performance
  • Identify opportunities for revenue optimization
  • Build and manage RCM account management, fully owning the layer between the clinics and RCM operations
  • Own client communication regarding billing performance, denials trends, payer issues, and operational questions
  • Establish trust and strong relationships with clinic stakeholders including practice owners, clinicians, and administrative staff
  • Build out best practices & processes for clinics to successfully maximize revenue collections
  • Work with internal product and engineering teams to suggest improvements to EHR & practice management and automation tooling
  • Partner with internal billing operations to triage and resolve denials, rejections, and underpayments
  • Drive continuous improvement in internal SOPs and handoffs between RCM, implementation, and success
Desired Qualifications
  • Knowledge of TMS, Spravato, or ketamine therapy billing requirements
  • Previous experience at a managed services organization or large medical group
  • Background in process optimization, automation, or AI implementation in healthcare operations

Osmind provides an EMR platform tailored for mental health professionals, including psychiatrists and therapists. It combines billing, scheduling, patient engagement, intake forms, and automated outcome measures in one easy-to-use system. The service is offered on a subscription basis, plus a flat-rate patient payment option with no per-transaction fees to streamline workflows. Its goal is to help clinicians deliver care more efficiently and increase patient access to innovative treatments.

Company Size

51-200

Company Stage

Series B

Total Funding

$57.1M

Headquarters

San Francisco, California

Founded

2020

Simplify Jobs

Simplify's Take

What believers are saying

  • Compass Pathways collaboration prepares clinics for FDA-approved psychedelics.
  • CareNet GPO partnership delivers SPRAVATO savings to 1,000+ practices.
  • Cybin partnership accelerates commercial rollout using Osmind's data platform.

What critics are saying

  • Epic's Canto module captures 60% psychiatry EHR market within 24 months.
  • Headspace acquires Power, eroding Osmind's share in 6-12 months.
  • FDA denies COMP360 approval, wasting Osmind's psychedelic R&D investments.

What makes Osmind unique

  • Osmind's EHR tailors workflows for ketamine, Spravato, TMS, and psychedelic therapies.
  • Osmind aggregates two million patient outcomes for real-world ketamine analyses.
  • Osmind networks over 1,000 independent interventional psychiatry practices nationwide.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Osmind who can refer or advise you

Benefits

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-4%

2 year growth

-4%
Postmedia Network
Apr 21st, 2025
Cybin Partners with Osmind to Accelerate Commercial Preparation for its Clinical-Stage Psychiatry Programs

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, today announced a strategic partnership with Osmind, a leading service provider advancing psychiatry through technology, services, and real-world evidence to bring innovative mental health treatments to patients in need.

Business Wire
May 2nd, 2024
Osmind Announces Collaboration with the American Psychiatric Association to Advance Quality Psychiatric Care and Accelerate Research

Osmind announces collaboration with the American Psychiatric Association to advance quality psychiatric care and accelerate research.

Business Wire
May 2nd, 2024
Osmind Announces Collaboration With The American Psychiatric Association To Advance Quality Psychiatric Care And Accelerate Research

SAN FRANCISCO--(BUSINESS WIRE)--Today, Osmind, the leading psychiatric treatment and research platform, announced an innovative collaboration with the American Psychiatric Association (APA) to improve the adoption of measurement-based care (MBC) and precision treatment in psychiatry. This collaboration between Osmind and APA’s PsychPRO registry intends to broaden access to personalized care, improve patient outcomes, generate robust real-world evidence (RWE) and accelerate psychiatry’s evolution to precision medicine. PsychPRO registry is a clinical data registry that enables the collection and analysis of clinical data to advance quality improvement efforts and accelerate research for the psychiatric community. "At Osmind, we emphasize the importance of clinicians participating in evidence-generating medicine to help shape the future of mental health care, especially as the psychiatric field begins to embrace new treatments and precision psychiatry,” said Carlene MacMillan, MD, Chief Medical Officer of Osmind. “Clinicians in private practice juggle many competing demands so it is crucial we make participation both easy and worthwhile to them.". Osmind is integrating a number of APA’s diagnostic and outcomes measures of interest, including the DSM-5-TR Self-Rated Level 1 Cross-Cutting Symptom Measure developed by APA researchers, into its electronic health record (EHR) software

Cision
Dec 5th, 2023
Osmind Announces Virtual 2023 Breakthrough Mental Health Treatment Forum To Advance Mental Health Research, Treatment, And Community

Starting today, mental health clinicians, practice owners, and researchers have free access to sessions led by the nation's foremost mental health clinicians driving breakthrough medicineSAN FRANCISCO, Dec. 5, 2023 /PRNewswire-PRWeb/ -- Osmind, the public benefit corporation helping clinicians and researchers advance life-saving mental health treatment, today announced its inaugural Breakthrough Mental Health Treatment Forum is now open to virtual attendees. Sessions will focus on mental health treatment research, how to build a successful practice, and the value of community in delivering care. The forum brings together psychiatrists, nurse practitioners, psychotherapists, scientists, clinicians, mental health practice leaders and administrators, and academics all dedicated to advancing therapeutic options for people facing severe and treatment-resistant mental illness."The mental health crisis continues to grow, yet critical advancements in psychiatric treatment are lagging behind," said Lucia Huang, co-founder and CEO of Osmind. "This forum is a unique space for those on the leading edge of novel therapeutic care to hear from leaders driving future innovations on the frontlines of breakthrough mental health care, helping more patients access effective care, and supporting future collaborations."The three-day forum will run from Tuesday, December 5 through Thursday, December 7. Content is available asynchronously

The Manchester Times
Oct 24th, 2023
Osmind Reimagines Insurance Reimbursement for Psychiatric Clinicians, Expanding Patient Access to Mental Health Care

Osmind, the public benefit corporation helping clinicians and researchers advance life-saving mental health treatment, today announced Osmind Claims, which introduces new billing capabilities purpose-built to simplify insurance reimbursement for psychiatric treatment, enabling greater access to insurance-supported mental health care.

INACTIVE